These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 33827588

  • 1. Ethical and legal issues in psychedelic harm reduction and integration therapy.
    Pilecki B, Luoma JB, Bathje GJ, Rhea J, Narloch VF.
    Harm Reduct J; 2021 Apr 07; 18(1):40. PubMed ID: 33827588
    [Abstract] [Full Text] [Related]

  • 2. Psychedelic Harm Reduction and Integration: A Transtheoretical Model for Clinical Practice.
    Gorman I, Nielson EM, Molinar A, Cassidy K, Sabbagh J.
    Front Psychol; 2021 Apr 07; 12():645246. PubMed ID: 33796055
    [Abstract] [Full Text] [Related]

  • 3. Microdosing psychedelics: Motivations, subjective effects and harm reduction.
    Lea T, Amada N, Jungaberle H, Schecke H, Klein M.
    Int J Drug Policy; 2020 Jan 07; 75():102600. PubMed ID: 31778967
    [Abstract] [Full Text] [Related]

  • 4.
    Chao YS, Horton J.
    ; 2021 06 07. PubMed ID: 36170470
    [Abstract] [Full Text] [Related]

  • 5. Ethical and Practical Considerations for the Use of Psychedelics in Psychiatry.
    Barber GS, Dike CC.
    Psychiatr Serv; 2023 Aug 01; 74(8):838-846. PubMed ID: 36987705
    [Abstract] [Full Text] [Related]

  • 6. Compassionate use of psychedelics.
    Greif A, Šurkala M.
    Med Health Care Philos; 2020 Sep 01; 23(3):485-496. PubMed ID: 32468195
    [Abstract] [Full Text] [Related]

  • 7. With great power comes great vulnerability: an ethical analysis of psychedelics' therapeutic mechanisms proposed by the REBUS hypothesis.
    Villiger D, Trachsel M.
    J Med Ethics; 2023 Nov 23; 49(12):826-832. PubMed ID: 37045591
    [Abstract] [Full Text] [Related]

  • 8. UK medical students' self-reported knowledge and harm assessment of psychedelics and their application in clinical research: a cross-sectional study.
    Song-Smith C, Jacobs E, Rucker J, Saint M, Cooke J, Schlosser M.
    BMJ Open; 2024 Mar 14; 14(3):e083595. PubMed ID: 38485474
    [Abstract] [Full Text] [Related]

  • 9. Attitudes and Beliefs about the Therapeutic Use of Psychedelic Drugs among Psychologists in the United States.
    Davis AK, Agin-Liebes G, España M, Pilecki B, Luoma J.
    J Psychoactive Drugs; 2022 Mar 14; 54(4):309-318. PubMed ID: 34468293
    [Abstract] [Full Text] [Related]

  • 10. Psychedelics and Evidence-based Psychotherapy: A Systematic Review with Recommendations for Advancing Psychedelic Therapy Research.
    Leone L, McSpadden B, DeMarco A, Enten L, Kline R, Fonzo GA.
    Psychiatr Clin North Am; 2024 Jun 14; 47(2):367-398. PubMed ID: 38724126
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Call for evidence-based psychedelic integration.
    Greń J, Gorman I, Ruban A, Tylš F, Bhatt S, Aixalà M.
    Exp Clin Psychopharmacol; 2024 Apr 14; 32(2):129-135. PubMed ID: 38010760
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006-2020.
    Barnett BS, Parker SE, Weleff J.
    Int J Drug Policy; 2022 Jan 14; 99():103473. PubMed ID: 34624734
    [Abstract] [Full Text] [Related]

  • 17. The Pharmacology and Clinical Applications of Psychedelic Medicines Within Midwifery Practice.
    Stein CA, Penn A, Van Hope S, Dorsen CG, Mangini M.
    J Midwifery Womens Health; 2022 May 14; 67(3):373-383. PubMed ID: 35522087
    [Abstract] [Full Text] [Related]

  • 18. Psychologists' and psychotherapists' knowledge, attitudes, and clinical practices regarding the therapeutic use of psychedelics.
    Kucsera A, Suppes T, Haug NA.
    Clin Psychol Psychother; 2023 May 14; 30(6):1369-1379. PubMed ID: 37394242
    [Abstract] [Full Text] [Related]

  • 19. Classic psychedelics in the treatment of substance use disorder: Potential synergies with twelve-step programs.
    Yaden DB, Berghella AP, Regier PS, Garcia-Romeu A, Johnson MW, Hendricks PS.
    Int J Drug Policy; 2021 Dec 14; 98():103380. PubMed ID: 34329952
    [Abstract] [Full Text] [Related]

  • 20. Psychedelic Group Therapy.
    Gasser P.
    Curr Top Behav Neurosci; 2022 Dec 14; 56():23-34. PubMed ID: 35091980
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.